Blog

In the early stages of pregnancy, as well as during the in vitro fertilization (IVF) process and after multiple miscarriages, a test may be offered to detect any abnormalities in the fetal chromosomes. Those abnormalities — causing either missing or extra chromosomes — can lead to congenital and genetic disorders or, in some cases, miscarriage.

University of Hong Kong (HKU) researchers develop wearable biosensing system: The new device can be integrated with a smartwatch and continuously monitors biosignals.

The FDA released a safety communication about a shortage of tracheostomy tubes due to problems in obtaining raw materials. The shortage, which includes tubes manufactured by ICU Medical, likely will most affect pediatric patients, and the FDA said tracheostomy tubes can be reused after following proper sanitary procedures during the shortage.

A sensor fashioned into jewelry can potentially be used as a non-invasive way to measure glucose and other vital signs

Researchers at MIT have developed a method that could be used to ensure long-lasting medical device implants do not trigger an immune response. The aim of their research is to allow implants to keep working without being rejected by the body.

The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. Facilities where use of ethylene oxide (EtO) presents a risk to communities

South Koreans may soon be able to carry a device inside their own bodies in the form of a bespoke tattoo that automatically alerts them to potential health problems, if a science team’s project bears fruit.

Among patients who received a smartwatch notification that they may have atrial fibrillation (AFib), 94% of those who followed up with a doctor were confirmed to indeed have the common heart rhythm disorder, according to a study presented at the American College of Cardiology (ACC) 2022 Annual Scientific Session.

The device tracks motion and provides feedback regarding the way a user may want to adjust their movement.

Among patients who received a smartwatch notification that they may have atrial fibrillation (AFib), 94% of those who followed up with a doctor were confirmed to indeed have the common heart rhythm disorder, according to a study presented at the American College of Cardiology (ACC) 2022 Annual Scientific Session.